Blockchain Registration Transaction Record

Cardio Diagnostics Pioneers Personalized Heart Care with AI and Epigenetics

Cardio Diagnostics (NASDAQ: CDIO) uses AI, epigenetics, and genetics to pioneer personalized heart care, shifting from reactive treatment to predictive prevention for cardiovascular disease.

This news matters because heart disease remains the leading cause of death worldwide, yet current healthcare often fails to prevent it. Cardio Diagnostics' approach could shift the paradigm from reactive treatment to proactive prevention, potentially saving lives by identifying risks earlier. For patients, this means more personalized and accessible care; for investors, it represents a growing opportunity in precision medicine. By leveraging AI and epigenetic insights, CDIO is at the forefront of a healthcare transformation that could reduce the burden of cardiovascular disease globally.